Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes

AIM: To evaluate the treatment effect Fand pharmacoeconomic value of Dugaglutide in women with type 2 diabetes. METHODS: Women (n=96) with type 2 diabetes recruited from June 2019 to December 2021 were randomized into two equal groups. The control group was treated with Liraglutide, and the observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu, Zhang, Shuo, Wu, Zezhen, Liu, Weiting, Chen, Jingxian, Deng, Feiying, Chen, Fengwu, Zhu, Dan, Hou, Kaijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899911/
https://www.ncbi.nlm.nih.gov/pubmed/36755915
http://dx.doi.org/10.3389/fendo.2023.1054946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899911/
https://www.ncbi.nlm.nih.gov/pubmed/36755915
http://dx.doi.org/10.3389/fendo.2023.1054946

Ejemplares similares